Stavros Stavrakis

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. doi request reprint Development and validation of a prognostic index for risk stratification of patients with early repolarization
    Stavros Stavrakis
    Department of Medicine Cardiovascular Section Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    Ann Noninvasive Electrocardiol 17:361-71. 2012
  2. doi request reprint Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function
    Stavros Stavrakis
    Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, OK, USA
    Am J Med Sci 345:211-7. 2013
  3. ncbi request reprint Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis
    Stavros Stavrakis
    Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, 920 Stanton L Young Blvd, WP 3010, Oklahoma City, OK 73104, USA
    Europace 14:1490-7. 2012
  4. pmc Culprit-vessel percutaneous coronary intervention followed by contralateral angiography versus complete angiography in patients with ST-elevation myocardial infarction
    Chadi Dib
    Department of Internal Medicine, Section of Cardiovascular Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    Tex Heart Inst J 39:359-64. 2012
  5. ncbi request reprint Coronary slow flow--prevalence and clinical correlations
    Beau M Hawkins
    Section of Cardiovascular Disease, Department of Internal Medicine, University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City, OK, USA
    Circ J 76:936-42. 2012
  6. doi request reprint Inhibition of atrial fibrillation by low-level vagus nerve stimulation: the role of the nitric oxide signaling pathway
    Stavros Stavrakis
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    J Interv Card Electrophysiol 36:199-208. 2013
  7. doi request reprint Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation
    Stavros Stavrakis
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    J Cardiovasc Electrophysiol 23:771-7. 2012
  8. ncbi request reprint Continuing medical education activity in echocardiography
    Pohoey Fan
    Heart Rhythm Institute, University of Oklahoma Heart Sciences Center, Oklahoma City, Oklahoma Cardiovascular Section, University of Oklahoma Heart Sciences Center, Oklahoma City, Oklahoma Department of Medicine, University of Oklahoma Heart Sciences Center, Oklahoma City, Oklahoma
    Echocardiography 28:774. 2011
  9. pmc Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension
    Xichun Yu
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA
    J Am Soc Hypertens 6:40-7. 2012
  10. doi request reprint Transesophageal echocardiographic assessment of pulmonary veins and left atrium in patients undergoing atrial fibrillation ablation
    Stavros Stavrakis
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
    Echocardiography 28:775-81. 2011

Collaborators

Detail Information

Publications16

  1. doi request reprint Development and validation of a prognostic index for risk stratification of patients with early repolarization
    Stavros Stavrakis
    Department of Medicine Cardiovascular Section Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    Ann Noninvasive Electrocardiol 17:361-71. 2012
    ..Early repolarization (ER) is associated with increased mortality in the general population. We sought to develop and validate a prognostic index (PI) of mortality in patients with ER...
  2. doi request reprint Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function
    Stavros Stavrakis
    Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, OK, USA
    Am J Med Sci 345:211-7. 2013
    ..In this study, the association of BMI, BNP levels and mortality in patients hospitalized for heart failure with preserved LV systolic function (HFpLVF) was investigated...
  3. ncbi request reprint Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis
    Stavros Stavrakis
    Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, 920 Stanton L Young Blvd, WP 3010, Oklahoma City, OK 73104, USA
    Europace 14:1490-7. 2012
    ..We performed a meta-analysis of randomized controlled trials to examine whether cardiac resynchronization therapy (CRT) is superior to right ventricular (RV) pacing in this patient population...
  4. pmc Culprit-vessel percutaneous coronary intervention followed by contralateral angiography versus complete angiography in patients with ST-elevation myocardial infarction
    Chadi Dib
    Department of Internal Medicine, Section of Cardiovascular Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    Tex Heart Inst J 39:359-64. 2012
    ....
  5. ncbi request reprint Coronary slow flow--prevalence and clinical correlations
    Beau M Hawkins
    Section of Cardiovascular Disease, Department of Internal Medicine, University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City, OK, USA
    Circ J 76:936-42. 2012
    ..Coronary slow flow phenomenon (CSFP) is defined as delayed coronary opacification in the absence of obstructive coronary artery disease. In the present study, we sought to define its prevalence and clinical features...
  6. doi request reprint Inhibition of atrial fibrillation by low-level vagus nerve stimulation: the role of the nitric oxide signaling pathway
    Stavros Stavrakis
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
    J Interv Card Electrophysiol 36:199-208. 2013
    ..We examined the role of the phosphatidylinositol-3 kinase (PI3K)/nitric oxide (NO) signaling pathway in low-level vagus nerve stimulation (LLVNS)-mediated inhibition of atrial fibrillation (AF)...
  7. doi request reprint Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation
    Stavros Stavrakis
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    J Cardiovasc Electrophysiol 23:771-7. 2012
    ..We examined the antiarrhythmic effects of vasostatin-1, a recently identified cardioregulatory peptide, in canine models of atrial fibrillation (AF)...
  8. ncbi request reprint Continuing medical education activity in echocardiography
    Pohoey Fan
    Heart Rhythm Institute, University of Oklahoma Heart Sciences Center, Oklahoma City, Oklahoma Cardiovascular Section, University of Oklahoma Heart Sciences Center, Oklahoma City, Oklahoma Department of Medicine, University of Oklahoma Heart Sciences Center, Oklahoma City, Oklahoma
    Echocardiography 28:774. 2011
    ..Article Title: Transesophageal Echocardiographic Assessment of Pulmonary Veins and Left Atrium in Patients Undergoing Atrial Fibrillation Ablation (Echocardiography 2011;28:774)...
  9. pmc Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension
    Xichun Yu
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA
    J Am Soc Hypertens 6:40-7. 2012
    ..Activating autoantibodies to β1/2-adrenergic (AAβ1/2AR) and M2/3 muscarinic receptors (AAM2/3R) produce vasodilative changes in the vasculature that may contribute to OH...
  10. doi request reprint Transesophageal echocardiographic assessment of pulmonary veins and left atrium in patients undergoing atrial fibrillation ablation
    Stavros Stavrakis
    Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
    Echocardiography 28:775-81. 2011
    ..The aim of this study was to evaluate acute changes in left atrial and PV flow velocities following PV antrum isolation with GP ablation using transesophageal echocardiography (TEE)...
  11. doi request reprint The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis
    Stavros Stavrakis
    Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
    J Cardiovasc Electrophysiol 23:163-8. 2012
    ..Whether this benefit is consistent across all degrees of QRS widening is unclear. We performed a meta-analysis of randomized clinical trials to evaluate the impact of QRS duration on the efficacy of CRT...
  12. doi request reprint Transesophageal echocardiography for the diagnosis of pulmonary vein stenosis after catheter ablation of atrial fibrillation: a systematic review
    Stavros Stavrakis
    Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
    Echocardiography 27:1141-6. 2010
    ..We undertook a systematic review of the literature to investigate the diagnostic performance of transesophageal echocardiography (TEE) for the detection of PV stenosis after catheter ablation of AF...
  13. pmc Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases
    Stavros Stavrakis
    Cardiology and the Heart Rhythm Institute, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, Oklahoma 73104, USA
    Int J Cardiol 148:331-6. 2011
    ..However, the interactions and relative effects of AAβ1AR, AAβ2AR and AAM2R on contractile function have not been characterized...
  14. ncbi request reprint Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions--a single-center experience
    Harsh Golwala
    Department of Internal Medicine, 920 Stanton L Young Boulevard, WP 3010, Oklahoma City, OK 73104, USA
    J Invasive Cardiol 24:1-3. 2012
    ..Our aim was to explore whether or not the under-utilization of EPDs led to any untoward cardiovascular events...
  15. doi request reprint Use of hydralazine-isosorbide dinitrate combination in african american and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction
    Harsh B Golwala
    Oklahoma University Health Science Center, VA Medical Center, Oklahoma City, OK
    J Am Heart Assoc 2:e000214. 2013
    ....
  16. doi request reprint Apparent acute reversible right ventricular pacing-induced left ventricular dysfunction
    Charles C Te
    Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190, USA
    J Cardiovasc Electrophysiol 24:224-6. 2013
    ..LV dysfunction resolved immediately with RV pacing turned off. To our knowledge, this is the first report of this phenomenon...